By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.
-
-
LUBRICANT EYE (Generic for REFRESH OPTIVE)
- QTY 30
- 0.3 %-0.4%
- DROPERETTE
- Near 77381
ARTIFICIAL TEARS (ahr tuh FISH uhl teerz) treats discomfort caused by dry eyes. It works by moisturizing and protecting the outer surface of your eyes.
Change Location
Set Price Drop Alert for:
LUBRICANT EYE (Generic for REFRESH OPTIVE)
- QTY 30
- 0.3 %-0.4%
- DROPERETTE
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
LUBRICANT EYE (Generic for REFRESH OPTIVE)
- QTY 30
- 0.3 %-0.4%
- DROPERETTE
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Change Form
Medicine Chest
LUBRICANT EYE (Generic for REFRESH OPTIVE) Lifestyle Interactions
-
Repotrectinib 40mg, Oral capsule
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.• Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during repotrectinib treatment due to the risk of increased repotrectinib exposure and adverse reactions. Repotrectinib is a CYP3A and P-gp substrate and grapefruit juice is a CYP3A and P-gp inhibitor.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
